← Open Payments lookup

MICHAEL FARLEY: Open Payments

NPI 1548802416 · NAMPA, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$946 in 40 payments from 10 companies in 2025. Trend: 2023 $834 · 2024 $453 · 2025 $946

Food & beverage: $946
CompanyPaymentsAmount
Novo Nordisk Inc15$342
AstraZeneca Pharmaceuticals LP12$292
ABBVIE INC.5$126
Amgen Inc.2$44
ABIOMED1$30
ALK-Abello, Inc1$30
PFIZER INC.1$27
Otsuka America Pharmaceutical, Inc.1$22
GlaxoSmithKline, LLC.1$21
Lilly USA, LLC1$15

Products named: Rybelsus, AIRSUPRA, BREZTRI, Wegovy, QULIPTA, EVENITY, Ozempic, UBRELVY.

Industry payments across ID — which companies pay providers there.